Category: Faculty
Corbett Promoted to Clinical Associate Professor
January 17, 2012Amanda Corbett, PharmD, has been promoted to clinical associate professor in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy. In addition to her appointment in the School, Corbett is a clinical assistant professor in the UNC School of Medicine, a clinical associate for the UNC Center for AIDS Research, and a member of the AIDS Clinical Trials Group Translational Research and Drug Development Scientific Committee, and a pharmacologist for the ACTG. “Since joining our faculty in 2003, Dr. Corbett has been a leader in researching the use of antiretrovirals and in exploring the treatment … Read more
Weeks Promoted to Elizabeth City Assistant Dean Post
January 12, 2012Latasha Weeks, PharmD, has accepted the position of regional assistant dean at Elizabeth City for the UNC Eshelman School of Pharmacy. Weeks is a clinical assistant professor in the School’s Division of Pharmacy Practice and Experiential Education. Weeks will oversee the School’s satellite campus in Elizabeth City, North Carolina, which was created in 2005 in partnership with Elizabeth City State University. She became the ECSU–based director of the UNC/ECSU Doctor of Pharmacy Partnership Program in 2010. She was formerly a clinical assistant professor at the University of Maryland School of Pharmacy and completed a community pharmacy residency at UNC-Chapel Hill. … Read more
Phil Rodgers Named Assistant Dean for Pharmacy Practice Partnerships
January 5, 2012Phil Rodgers, PharmD, has been named as the assistant dean for pharmacy practice partnerships at the UNC Eshelman School of Pharmacy. As assistant dean, he will provide overall leadership and financial oversight for the Professional Experience Program and be heavily engaged in the scholarship of pharmacy practice as well as in developing innovative methods to train students and residents to advance pharmacy practice. “I am extremely pleased that Phil Rodgers has joined us,” says Bob Blouin, PharmD, dean of the School. “Our relationships with and the quality of our preceptors and community-based faculty are of critical importance to the School. … Read more
Professor Tim Ives to Chair AACP Board of Sections
December 26, 2011Professor Timothy Ives, PharmD, MPH, has been elected as the chair of the Council of Sections for the American Association of Colleges of Pharmacy and will serve on the AACP board of directors as part of his responsibilities. The primary focus of the council is to represent the collective interests of the academic disciplines within pharmacy education to the AACP and its board of directors. Ives’ three-year term will officially begin at the 2012 AACP Annual Meeting, which will be held July 14-18 in Kissimmee, Florida. Ives, who joined the School in 1981, is a faculty member in the Division … Read more
UNC Study Could Lead to Treatment for Angelman Syndrome
December 21, 2011Results of a new study by a team of researchers at the University of North Carolina at Chapel Hill may help pave the way to a treatment for Angelman syndrome, a neurogenetic disorder for which there is currently no effective therapy. The most characteristic feature of AS is the absence or near absence of speech throughout the person’s life. The disease, often misdiagnosed as cerebral palsy or autism, is caused by mutations or deletions in the Ube3a gene inherited from the mother, or the maternal allele. The Ube3a protein produced by that gene is a key component of an important … Read more
Associate Professor Wiltshire Receives Tenure
December 19, 2011Associate professor Tim Wiltshire, PhD, has received tenure at the UNC Eshelman School of Pharmacy. Wiltshire joined the School’s Division of Pharmacotherapy and Experimental Therapeutics in 2007. He serves as the associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy. He also holds adjunct faculty positions in the UNC Lineberger Comprehensive Cancer Center and in theDepartment of Genetics at the UNC School of Medicine. In addition, he is actively involved in several collaborations with the Hamner Institutes for Health Sciences. Before coming to UNC, Wiltshire was a senior research investigator at the Genomics Institute of the Novartis Research … Read more
When Prophecy Fails: How to Better Predict Success in HIV Prevention Clinical Trials
December 12, 2011New research from the University of North Carolina at Chapel Hill schools of medicine and pharmacy may help explain the failure of some recent clinical trials of prevention of HIV infection compared to the success of others that used the same drugs. The study published online December 7 in the journal Science Translational Medicine, also suggests how to improve the chances for success, even before the research begins. These suggestions are reinforced in an editorial by several of the UNC authors writing in The Lancet, also published online December 7. Over the past two years, results from several clinical trials … Read more
HIV Expert Angela Kashuba Promoted to Full Professor
December 7, 2011The University of North Carolina at Chapel Hill Board of Trustees has approved the promotion of Angela Kashuba, PharmD, to the rank of full professor in the UNC Eshelman School of Pharmacy. “In the past thirty years, AIDS has gone from being a death sentence to a manageable condition to being only a few years away from a cure. Dr. Kashuba has been a major contributor to the effort that has made this possible and a leader here at the School,” says Dean Bob Blouin, PharmD. Kashuba is a member of the Division of Pharmacotherapy and Experimental Therapeutics, director of … Read more
Ming Receives Grant to Study Therapy for Renal Fibrosis
November 28, 2011Xin Ming, PhD, a research assistant professor at the UNC Eshelman School of Pharmacy, has received an NC TraC$50K Pilot Grant from the North Carolina Translational and Clinical Sciences Institute to support his research on using targeted siRNA therapy to treat renal fibrosis. The one-year grant will provide $50,000 to support Ming’s study of a therapy targeting αvβ6 integrin receptors that play a crucial role in fibrogenesis, the formation of scar tissues in an organ. Ming, a faculty member in the Division of Molecular Pharmaceutics, will use this study to generate preliminary data to apply for an R01 grant from … Read more
Frye Promoted to Full Professor with Tenure
November 23, 2011The University of North Carolina at Chapel Hill Board of Trustees has approved the promotion of Stephen Frye, PhD, to the rank of full professor with tenure in the UNC Eshelman School of Pharmacy. Frye is the director of the School’s Center for Integrative Chemical Biology and Drug Discovery, a research group bringing dedicated medicinal chemistry expertise to bear on biological targets of therapeutic relevance under investigation by UNC faculty. CIBDD project teams work with other groups on campus to move potential drug targets through the drug discovery and development process. “This promotion is due recognition of the impressive contribution … Read more